Pushing the limits of treatment for hepatocellular carcinoma

M Jones-Pauley, DW Victor III… - Current Opinion in Organ …, 2024 - journals.lww.com
HCC is rising in incidence and patients are often diagnosed at later stages. Consequently,
there is a need for treatment strategies which include collaboration of multiple specialties …

Applications of Yttrium-90 (90Y) in Hepatocellular Carcinoma

ZH Jiang, F Yang, WX Wang - OncoTargets and Therapy, 2024 - Taylor & Francis
Hepatocellular carcinoma (HCC) is the most common primary liver cancer, affecting millions
of people worldwide. Due to the lack of systemic radiation therapy in hepatocellular …

Transarterial radioembolization (TARE) in patients with hepatocellular carcinoma: a comparison of palliative with bridging-to-transplant concepts

J Schönherr, P Seifert, F Gühne, T Winkens… - Cancers, 2024 - mdpi.com
Simple Summary Liver transplantation (LT) is the best potentially curative treatment for
unresectable, early-stage hepatocellular carcinoma (HCC) in cirrhotic patients. Bridging-to …

Yttrium-90 transarterial radioembolization of primary lung cancer metastases to the liver

ES Alexander, EN Petre, K Zhao, V Sotirchos… - Journal of Vascular and …, 2024 - Elsevier
Purpose To assess whether yttrium-90 transarterial radioembolization (TARE) is safe and
effective in the treatment of primary lung cancer metastases to the liver (LCML). Methods …

PET/CT and SPECT/CT imaging of 90Y hepatic radioembolization at therapeutic and diagnostic activity levels: Anthropomorphic phantom study

A Budzyńska, A Kubik, K Kacperski, P Pastusiak… - Plos one, 2024 - journals.plos.org
Purpose Prior to 90Y radioembolization procedure, a pretherapy simulation using 99mTc-
MAA is performed. Alternatively, a small dosage of 90Y microspheres could be used. We …

[HTML][HTML] Pretreatment Embolization of Tumoral Arteriovenous Fistula Associated With Recanalized Umbilical Vein Shunt in a Case of Hepatocellular Carcinoma With …

J Almaguer, A Khan, A Saleem - Cureus, 2023 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the most common liver cancer and has a propensity to
develop arteriovenous fistulas with the surrounding vasculature, making targeted …

[HTML][HTML] Diagnosis and management of radiation cholecystitis as a complication of Y90 radioembolization for hepatocellular carcinoma

J Khoury, B Li, J Zhu, T Lin, E Hasan, A Lamba… - Radiology Case …, 2024 - Elsevier
Radiation induced cholecystitis is a known but rare complication of Yttrium90 (Y90)
radioembolization of hepatic tumors due to nontarget embolization. Many documented …

[PDF][PDF] Pre-transarterial Radioembolization of Tumoral Arteriovenous Fistula Associated With Recanalized Umbilical Vein Shunt in a Case of Hepatocellular …

J Almaguer, A Khan, A Saleem - Cureus, 2023 - cureus.com
Hepatocellular carcinoma (HCC) is the most common liver cancer and has a propensity to
develop arteriovenous fistulas with the surrounding vasculature, making targeted …

[引用][C] Pre-TARE Embolization of Tumoral Arteriovenous Fistula Associated with Recanalized Umbilical Vein Shunt in A Case of Hepatocellular Carcinoma with …

J Almaguer, A Khan, A Saleem - europepmc.org
Hepatocellular carcinoma (HCC) is the most common liver cancer and has a propensity to
develop arteriovenous fistulas with the surrounding vasculature, making targeted …